Please assess the completion status of the following clinical trial:

Trial Title: A Study of an Automated Insulin Delivery System in Adult Participants With Type 1 Diabetes Mellitus (T1D)

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DEVICE_FEASIBILITY
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
* Participants with T1DM for at least 2 years and who have used an insulin delivery system with any rapid-acting insulin analog for the preceding 6 months~* Have a body mass index of 18.5 to 37 kilogram per meter squared~* Have a hemoglobin A1c level ≥6.0% and ≤9.0%~Exclusion Criteria:~* Have known allergies or history of hypersensitivity to insulin lispro~* Have had an episode of severe hypoglycemia within the past 6 months~* Have had more than 1 episode of diabetic ketoacidosis in the past 6 months

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- AID System Containing Insulin Lispro (Type: EXPERIMENTAL): The AID system is comprised of a continuous subcutaneous insulin infusion (CSII) pump component with a hybrid closed-loop control (HCLC) algorithm, and a continuous glucose monitor (CGM) component.

Based on this trial design, predict the completion outcome and termination type (if applicable).